Ricardo Henriques

Hovione FarmaCiencia SA manufactures and distributes active pharmaceutical ingredients. Its services include contract manufacturing services, off-patent API products, proprietary product licensing, and supporting capabilities. The company was founded by Diane de Lancastre Houssemayne Du Boulay Villax, Ivan Villax, Nicholas de Horthy and Andrew Onody in 1959 and is headquartered in Loures, Portugal.

LaserLeap Technologies SA provides biomedical science and research services. Its technology is applied in cosmetics, anaesthetics and analgesics, therapeutics and vaccines. The company was founded in 2011 by Luis Guilherme da Silva Arnaut Moreira, Carlos Alberto Lourenço de Serpa Soares and Gonçalo de F.F. Sa and is headquartered in Coimbra, Portugal.

Alba Therapeutics Corporation is a privately held, clinical-stage biopharmaceutical Company focused on the discovery, development and commercialization of pharmaceutical products to treat autoimmune and inflammatory diseases and is based in Baltimore, Maryland. Genetics, environment, aberrant immune response, and barrier dysfunction are all required for autoimmunity. Alba's technology platform is based on modifying disease state epithelial permeability using compounds which impact the regulation of tight junctions in cell barriers throughout the body with potential applications in celiac disease, Crohn's disease, asthma/COPD and acute lung injury. As a development stage company Alba maximizes value creation by leveraging its human capital, partnerships and technology. Since the Company's formation in 2004, the company has entered human clinical trials with its lead product, received Fast Track designation from the FDA (in Celiac Disease), successfully completed three Phase I clinical trials and completed its first Phase II study. Along with $30m raised in its Series A financing, equity and non-equity capital, such as SBIR and ATP grants and venture debt, are being used to develop products, enhance its powerful IP position and build the Company's infrastructure and core competencies

AnyBrain SA provides software development services. It provides real-time, non-intruive, notifications and data analysis. The company was founded by Olaide Olambiwonnu, André Pimenta, Serafim Pinto, Davide Carneiro and Paulo Novais and is headquartered in Braga, Portugal.

Part of Adapttech Ltd., Adtechnologies Ltd. is a British biomedical innovation company that aims to enhance mobility and improve the quality of life for people with physical limitations through the development of data-driven and patient-centred technologies that are transforming the prosthetic field. The company is based in Birmingham, UK. Adtechnologies has developed Motio Stepwatch, an innovative wearable medical device designed for lower-limb prosthetic users. The device tracks patients' daily activities, providing clinicians with comprehensive reports that merge quantitative real-world data with results from Gold Standard tests to support the determination of each patient's K-level. The company was founded in 2015 by Joao Martins, Espinoza Mario Saenz, Frederico Alberto de Abreu Carpinteiro.

Senzer Ltd. is a British UK-based inhalation technology company founded in 2015. Senzer's location is in Salisbury, UK. The private company specializes in developing and commercializing therapeutic delivery systems of cannabinoid products. Senzer's platform is based on a patented device that allows swift and effective inhaled delivery of cannabinoids in a consistent dose-controlled presentation. The company is developing a pipeline of inhalation and delivery products to meet unmet medical needs.

Solascure Ltd. operates as a biotech company that develops wound care products. The company was founded by Benjamin Newmark and Sam Bakri in 2017 and is headquartered in Cardiff, the United Kingdom.

Adapttech Ltd. is a British company that specializes in developing innovative biomedical devices. The company is based in Birmingham, UK, and has subsidiaries in the United Kingdom. The company's Motio Stepwatch is a wearable medical device designed for lower-limb prosthetic users that tracks patients' daily activities and provides comprehensive reports to clinicians. The reports merge quantitative real-world data with results from Gold Standard tests to support the determination of each patient's K-level. The company aims to enhance mobility and improve the quality of life for people with physical limitations through cutting-edge biomedical innovations. The company was founded by Frederico Carpinteiro, who has been the CEO since incorporation.

Indaco Venture Partners Sgr SpA (Indaco Ventures) is venture capital firm founded in 2016 by Davide Turco, Elizabeth Robinson, Antonella Beltrame, and Alvise Bonivento. The firm is headquartered in Milan, Italy.

Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005.

Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal.

MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.

Celimmune LLC is a private company that engages in treating and preventing autoimmune diseases. The company is based in Lebanon, NJ. The company was founded by Ashleigh W. Palmer, Francisco Leon.

Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ.

Glutenostics LLC engages in the manufacture of urine and stool test products and retail through online. The company was founded by Angel Cebolla Ramirez and Francisco Leon in 2016 and is headquartered in Los Angeles, CA.

The United States Pharmacopeia engages in manufacturing medicines. It offers dietary supplements, and foods. The company is headquartered in Rockville, MD.

Araclon Biotech SL researches and develops therapies and diagnostic methods for Alzheimer’s disease. Its research areas include early diagnosis of Alzheimer’s disease; therapy for Alzheimer’s disease; development of a predictive test for the Alzheimer’s disease in asymptomatic individuals; and development of therapy for Parkinson’s disease. The company was founded on January 27, 2004 and is headquartered in Zaragoza, Spain.

Genetrix SL develops biotechnological solutions. It is comprised of technology and biomedicine companies in order to maximize the value of the Group. The company was founded in May 20, 2003 and is headquartered in Madrid, Spain.

Antibióticos de León SLU develops, manufactures, sells, and distributes active pharmaceutical ingredients for penicillin-based antibiotics. Its products include sterile antibiotics and oral semisynthesis. The company was founded in 2014 and is headquartered in Leon, Spain.